Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B infection. It contains hepatitis B surface antigen (rDNA) and alum as an adjuvant. This vaccine is administered intramuscularly or subcutaneously.

Engerix-B is used to protect against hepatitis B, a viral infection that can cause serious liver damage. It is typically administered to individuals at risk of exposure to the virus, such as healthcare workers, travelers to regions with high hepatitis B prevalence, and those with chronic liver disease. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus.

Common effects of Engerix-B may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve within a few days.

Engerix-B should be administered with caution in individuals with a history of severe allergic reactions to previous doses of hepatitis B vaccine or any of its components. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. The vaccine should be stored and handled according to the manufacturer's guidelines to ensure its effectiveness.

Engerix-B may interact with certain medications or other vaccines. It is advisable to consult with a healthcare provider before receiving the vaccine if you are taking any medications or have recently received other vaccines. Alcohol and certain immunosuppressant drugs may affect the immune response to the vaccine.